Document is current

Article History

Received: 1 April 2021

Accepted: 17 June 2021

First Online: 9 July 2021

Declarations

:

: L. Maisch, J. Spieß, S. Schneider, U. Ravens and D. Haase declare that they have no competing interests. R. Birkemeyer reports non-financial support from Preventicus and Daiichi Sankyo during the conduct of the study, and personal fees from Daiichi Sankyo outside the submitted work; he is also performing telecare services for Preventicus. T. Dahme reports personal fees from Daiichi Sankyo outside the submitted work. K. Althaus reports personal fees from Daiichi Sankyo, Boehringer and BMS for lectures outside the submitted work. U. Schotten received consultancy fees or honoraria from Università della Svizzera Italiana (USI, Switzerland), Roche Diagnostics (Switzerland), EP Solutions Inc. (Switzerland), Johnson & Johnson Medical Limited (United Kingdom), Bayer Healthcare (Germany). U. Schotten is co-founder and shareholder of YourRhythmics BV, a spin-off company of the University Maastricht.

: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.